FLUDARABINE AND CYCLOPHOSPHAMIDE (FC) VERSUS CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE (CVP) AS FIRST LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Ionita, H. [1 ]
Chreveresan, L. [1 ]
Mihaescu, R. [1 ]
Ionita, I. [1 ]
Isac, A. [1 ]
Cheveresan, M. [2 ]
Oros, D. [1 ]
Iordache, M. [1 ]
Musta, I. [1 ]
Basa, N. [1 ]
Delamarian, M. [2 ]
机构：
[1] Univ Med & Farm Timisoara, Timisoara, Romania
[2] Cty Hosp, Dept Hematol, Timisoara, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：468 / 468
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN ADVANCED STAGES - A RANDOMIZED TRIAL COMPARING CHLORAMBUCIL PLUS PREDNISONE VERSUS CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE
    MONTSERRAT, E
    ALCALA, A
    PARODY, R
    DOMINGO, A
    GARCIACONDE, J
    BUENO, J
    FERRAN, C
    SANZ, MA
    GIRALT, M
    RUBIO, D
    ANTON, I
    ESTAPE, J
    ROZMAN, C
    CANCER, 1985, 56 (10) : 2369 - 2375
  • [22] Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia
    Schiavone, EM
    De Simone, M
    Palmieri, S
    Annunziata, M
    Pocali, B
    Copia, C
    D'Amico, MR
    Del Vecchio, L
    Ferrara, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (01) : 23 - 28
  • [23] COMPARISON OF FLUDARABINE, CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE, AND CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE IN ADVANCED FORMS OF CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS OF A CONTROLLED CLINICAL-TRIAL
    FENAUX, P
    BINET, JL
    MALOUM, K
    LEPORRIER, M
    RAPP, MJ
    PIGUET, H
    BRION, A
    BOUDJERRA, N
    DREYFUS, B
    LEBLAY, R
    STOPPA, AM
    AUTRAND, JP
    SEBBAN, C
    PAITEL, JF
    MAISONNEUVE, P
    ROUSSET, T
    LINASSIER, M
    BRICE, P
    TRAVADE, P
    DIVINE, M
    DESABLENS, B
    JAUBERT, J
    ALLARD, C
    CHERON, D
    EGHBALI, JP
    CELIGNY, PS
    BORDESSOULE, D
    PIGNON, B
    VAUGIER, G
    LEJEUNE, F
    SALLES, B
    DEVIDAS, M
    BLANC, M
    MAIGRE, M
    REIGNER, A
    SIMON, P
    CHRISTIAN, B
    SCHVED, JF
    DOIRON, P
    RODON, M
    CARDE, P
    YAKOUB, I
    SOUTEYRAND, P
    RENOUX, M
    FACQUETDANIS, J
    HAMIDOU, M
    TURPIN, F
    DOR, JF
    FERMAND, JP
    VIGNERON, N
    SEMINARS IN ONCOLOGY, 1993, 20 (05) : 21 - 23
  • [24] Lumiliximab with fludarabine, cyclophosphamide, and rituximab (FCR) for patients with relapsed chronic lymphocytic leukemia (CLL).
    O'Brien, S.
    Byrd, J. C.
    Kipps, T. J.
    Forero-Torres, A.
    Flinn, I. W.
    Wynne, D. I.
    Molina, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 360S - 360S
  • [25] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [26] FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, ADRIAMYCIN, PREDNISONE (CAP) FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA - RESULTS OF A MULTINATIONAL PROSPECTIVE RANDOMIZED TRIAL
    HIDDEMANN, W
    JOHNSON, S
    SMITH, A
    BJORKHOLM, M
    LOFFLER, H
    WYLDE, P
    BINET, JL
    BLOOD, 1993, 82 (10) : A199 - A199
  • [27] Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone
    Bowen, Deborah A.
    Call, Timothy G.
    Shanafelt, Tait D.
    Kay, Neil E.
    Schwager, Susan M.
    Reinalda, Megan S.
    Rabe, Kari G.
    Slager, Susan L.
    Zent, Clive S.
    LEUKEMIA & LYMPHOMA, 2010, 51 (04) : 620 - 627
  • [28] THE EVALUATION OF EFFICACY AND TOXITY OF THE FIRST LINE THERAPY WITH FLUDARABINE COMBINED WITH CYCLOPHOSPHAMIDE (FC) VERSUS. 2-CHLORODEOXYADENOSINE WITH CYCLOPHOSPHAMIDE (CC) IN CHRONIC LYMPHOCYTIC B-CELL LEUKEMIA (CLL) SUBJECTS - THE OWN STUDY REPORT
    Ceglarek, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 603 - 604
  • [29] Fludarabine versus fludarabine plus cyclophosphamide as first line therapy of advanced chronic lymphocytic leukemia (CLL):: First interim analysis of a phase III study (CLL4 protocol) of the German CLL study group (GCLLSG).
    Schmitt, BF
    Bergmann, M
    Busch, R
    Wendtner, CM
    Pasold, R
    Anders, O
    Sezer, O
    Hurtz, HJ
    Söling, U
    Steinbrecher, C
    Emmerich, B
    Hallek, M
    BLOOD, 2001, 98 (11) : 633A - 633A
  • [30] Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study
    Zhu, Huayuan
    Shen, Hui
    Yang, Yilian
    Ding, Chong-Yang
    Sha, Yeqin
    Mi, Hongling
    Qiu, Jingyan
    Chen, Ruize
    Wu, Yujie
    Qiao, Chun
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2020, 136
12345